Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Media General Q1 Loss Widens - Quick Facts

RELATED NEWS
Trade MEG now with 

Media General Inc. (MEG: Quote) reported that its first-quarter net loss was $34 million, or $1.53 per share, compared with a net loss of $26 million, or $1.15 per share, in the 2011 first quarter.

First-quarter 2012 results included debt modification costs of $10 million related to the amendment of the company's bank credit facility, including legal, advisory and arrangement fees related to the refinancing. Interest expense in the first quarter of 2012 decreased 8.5 percent from last year.

Total revenues in the 2012 first quarter of $150 million increased 0.4 percent from last year on the strength of higher Broadcast revenues, partially offset by lower Print and Digital Media revenues.

Click here to receive FREE breaking news email alerts for Media General and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
While stocks have largely maintained a positive bias over the course of the trading day on Thursday, the major averages are turning in a mixed performance in mid-day trading. The S&P 500 has reached a new record intraday high and the Dow has climbed back above 17,000, while the tech-heavy Nasdaq is posting a modest loss. Suggesting that the economy is gaining traction, the Conference Board released a report on Thursday showing a bigger than expected increase by its index of leading U.S. economic indicators in July. Results of a survey released by the Federal Reserve Bank of Philadelphia on Thursday showed that regional manufacturing activity unexpectedly grew at an accelerated rate in the month of August, with the index of activity in the sector reaching a three-year high.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.